<DOC>
	<DOCNO>NCT02962830</DOCNO>
	<brief_summary>The fetus may expose pregnancy nociceptive stimulus fetal pathology ( e.g. , malformation ) diagnostic therapeutic procedure . To date , little data consensus fetal analgesia . The aim investigator study evaluate pharmacokinetics Sufentanil intra amniotic injection .</brief_summary>
	<brief_title>Sufentanil Pharmacokinetics After Intra Amniotic Injection</brief_title>
	<detailed_description />
	<mesh_term>Sufentanil</mesh_term>
	<criteria>Termination pregnancy fetal malformation Gestational age &gt; 24 week gestation Multiple pregnancy Allergy contraindication sufentanil Morphinic addiction fetal gastroschisis , omphalocele swallow disorder maternal cardiac respiratory distress</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>fetal pain</keyword>
	<keyword>fetal analgesia</keyword>
</DOC>